EV/EBITDA
-3.83
+0.08+2.05%
Thu, 06 Feb 2025 23:17:27 GMT
Summary
- As of February 7, 2025, CRDL EV/EBITDA is -3.83, with a rise of +0.08 (+2.05%) during the most recent trading day.
- Over the past year, CRDL EV/EBITDA has dropped by -1.50 (-64.38%).
- CRDL EV/EBITDA is now -932.61% below its all-time high of 0.46.
Performance
CRDL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRDL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.0% | -2.1% | -1.9% |
| 1 m1 month | -4.9% | +4.8% | +4.3% |
| 3 m3 months | +23.6% | -23.6% | -23.7% |
| 6 m6 months | +19.5% | -3.8% | -21.6% |
| ytdytd | -11.0% | +11.0% | +9.8% |
| 1 y1 year | -64.4% | +109.4% | +22.8% |
| 5 y5 years | +46.1% | +47.3% | -51.7% |
CRDL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -23.6% | -4.01 | +4.5% | |
| 3 m | 3-month | -3.10 | -23.6% | -5.41 | +29.2% |
| 6 m | 6-month | -3.10 | -23.6% | -6.66 | +42.5% |
| 1 y | 1-year | -1.88 | -103.7% | -8.40 | +54.4% |
| 3 y | 3-year | 0.46 | -932.6% | -8.40 | +54.4% |
| 5 y | 5-year | 0.46 | -932.6% | -8.40 | +54.4% |
| alltime | all time | 0.46 | -932.6% | -11.35 | +66.3% |
Cardiol Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.83(+11.0%) |
| 2024 | -3.45(+180.5%) |
| 2023 | -1.23(-451.4%) |
| Date | Value |
|---|---|
| 2022 | 0.35(-121.9%) |
| 2021 | -1.60(-59.5%) |
| 2020 | -3.95(-53.4%) |
| 2019 | -8.47 |
FAQ
- What is Cardiol Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cardiol Therapeutics?
- What is CRDL EV/EBITDA year-to-date change?
- What is Cardiol Therapeutics EV/EBITDA year-on-year change?
What is Cardiol Therapeutics EV/EBITDA?
The current EV/EBITDA of CRDL is -3.83
What is the all time high EV/EBITDA for Cardiol Therapeutics?
Cardiol Therapeutics all-time high EV/EBITDA is 0.46
What is CRDL EV/EBITDA year-to-date change?
Cardiol Therapeutics EV/EBITDA has changed by -0.38 (-11.01%) since the beginning of the year
What is Cardiol Therapeutics EV/EBITDA year-on-year change?
Over the past year, CRDL EV/EBITDA has changed by -1.50 (-64.38%)